This issue of Rheumatic Disease Clinics, guest edited by Drs. Xenofon Baraliakos and Michael H. Weisman, Spondyloarthritis: The Changing Landscape Today, takes a very comprehensive look at all of the essential topics surrounding spondyloarthritis. This issue is one of four selected each year by Dr. Weisman, who is also our series consulting editor. This very comprehensive issue will include the following topics (among others): Molecular biology approaches to understanding SpA; Microbiome and its role in SpA; Classification criteria in axSpA; Administrative data and coding for axSpA; Approach to the patient with IBD and AxSpA; Axial PsA vs. Axial SpA with Psoriasis; Emerging imaging techniques in SpA; The future of imaging in axSpA; Treatment Recommendations vs. Treat to Target in axSpA; The future of axSpA treatmentAxSpA in the era of Precision Medicine; Quality of Life as an outcome in studies of axSpA; Gender differences in SpA; The patient’s perspective on the burden of disease in axSpA; and Juvenile SpA.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. Genetics and Juvenile SpA - p. 14 9. Pathogenesis of Axial Spondyloarthritis — Sources and Current State of Knowledge - p. 193 10. Molecular Biology Approaches to Understanding Spondyloarthritis - p. 207 11. Intestinal Microbiota, HLA-B27, and Spondyloarthritis: Dangerous Liaisons - p. 213 12. What Does Human Leukocyte Antigen B27 Have to Do with Spondyloarthritis? - p. 225 13. Juvenile-Versus Adult-Onset Spondyloarthritis: Similar, but Different - p. 241 14. Referral/Diagnosis - p. 261 15. Classification Criteria in Axial Spondyloarthritis: What Have We Learned; Where Are We Going? - p. 259 16. EAMs - p. 278 17. Approach to the Patient with Axial Spondyloarthritis and Suspected Inflammatory Bowel Disease - p. 275 18. Imaging - p. 290 19. Emerging Imaging Techniques in Spondyloarthritis: Dual-Energy Computed Tomography and New MRI Sequences - p. 287 20. The Future of Imaging in Axial Spondyloarthritis - p. 297 21. Can Imaging Be a Proxy for Remission in Axial Spondyloarthritis? - p. 311 22. Treatment and Outcomes - p. 329 23. Axial Psoriatic Arthritis: A Distinct Clinical Entity in Search of a Definition - p. 327 24. Treat to Target in Axial Spondyloarthritis: Pros, Cons, and Future Directions - p. 343 25. The Future of Axial Spondyloathritis Treatment - p. 357 26. Axial Spondyloarthritis in the Era of Precision Medicine - p. 367 27. (Health-Related) Quality of Life as an Outcome in Studies of Axial Spondyloarthritis - p. 379 28. Patient´s perspective - p. 397 29. The Patient’s Perspective on the Burden of Disease in Ankylosing Spondylitis - p. 395 30. AS Patient: How to Cope with the Lifelong and Changing Disease Challenges - p. 403
This issue of Rheumatic Disease Clinics, guest edited by Drs. Xenofon Baraliakos and Michael H. Weisman, Spondyloarthritis: The Changing Landscape Today, takes a very comprehensive look at all of the essential topics surrounding spondyloarthritis. This issue is one of four selected each year by Dr. Weisman, who is also our series consulting editor. This very comprehensive issue will include the following topics (among others): Molecular biology approaches to understanding SpA; Microbiome and its role in SpA; Classification criteria in axSpA; Administrative data and coding for axSpA; Approach to the patient with IBD and AxSpA; Axial PsA vs. Axial SpA with Psoriasis; Emerging imaging techniques in SpA; The future of imaging in axSpA; Treatment Recommendations vs. Treat to Target in axSpA; The future of axSpA treatmentAxSpA in the era of Precision Medicine; Quality of Life as an outcome in studies of axSpA; Gender differences in SpA; The patient’s perspective on the burden of disease in axSpA; and Juvenile SpA.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. Genetics and Juvenile SpA - p. 14 9. Pathogenesis of Axial Spondyloarthritis — Sources and Current State of Knowledge - p. 193 10. Molecular Biology Approaches to Understanding Spondyloarthritis - p. 207 11. Intestinal Microbiota, HLA-B27, and Spondyloarthritis: Dangerous Liaisons - p. 213 12. What Does Human Leukocyte Antigen B27 Have to Do with Spondyloarthritis? - p. 225 13. Juvenile-Versus Adult-Onset Spondyloarthritis: Similar, but Different - p. 241 14. Referral/Diagnosis - p. 261 15. Classification Criteria in Axial Spondyloarthritis: What Have We Learned; Where Are We Going? - p. 259 16. EAMs - p. 278 17. Approach to the Patient with Axial Spondyloarthritis and Suspected Inflammatory Bowel Disease - p. 275 18. Imaging - p. 290 19. Emerging Imaging Techniques in Spondyloarthritis: Dual-Energy Computed Tomography and New MRI Sequences - p. 287 20. The Future of Imaging in Axial Spondyloarthritis - p. 297 21. Can Imaging Be a Proxy for Remission in Axial Spondyloarthritis? - p. 311 22. Treatment and Outcomes - p. 329 23. Axial Psoriatic Arthritis: A Distinct Clinical Entity in Search of a Definition - p. 327 24. Treat to Target in Axial Spondyloarthritis: Pros, Cons, and Future Directions - p. 343 25. The Future of Axial Spondyloathritis Treatment - p. 357 26. Axial Spondyloarthritis in the Era of Precision Medicine - p. 367 27. (Health-Related) Quality of Life as an Outcome in Studies of Axial Spondyloarthritis - p. 379 28. Patient´s perspective - p. 397 29. The Patient’s Perspective on the Burden of Disease in Ankylosing Spondylitis - p. 395 30. AS Patient: How to Cope with the Lifelong and Changing Disease Challenges - p. 403
